Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001854270-22-000055
Filing Date
2022-12-12
Accepted
2022-12-12 08:20:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a202212128kdoc424b3suppl2.htm 424B3 36197
2 senti_logoxfilings.jpg GRAPHIC 3916
  Complete submission text file 0001854270-22-000055.txt   42942
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267390 | Film No.: 221456226
SIC: 2836 Biological Products, (No Diagnostic Substances)